Evidence map›Paper›PMID 27766774›Full record

ArticleThoracic cancer2016

Incidence rate of female breast cancer in urban Shijiazhuang in 2012 and modifiable risk factors.

Denggui Wen, Yutong He, Lizhen Wei, Nan Zhang, Shumei Li, Xiaoduo Wen, Yi Yang, Guiying Wang, Shijie Wang, Cuizhi Geng and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thoracic cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The Expression Level ofIranian journal of public health · 2019
    Article
  3. Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Denggui WenDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yutong HeDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Lizhen WeiDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Nan ZhangDepartment of Medical Information, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Shumei LiDepartment of Medical Information, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Xiaoduo WenDepartment of Medical Imaging, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yi YangDepartment of Medical Imaging, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Guiying WangDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Shijie WangDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Cuizhi GengDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yunjiang LiuDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Baoen ShanDepartment of Cancer Research, Cancer Center of Hebei Province and The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is diagnosed more frequently among urban than rural women in China; however, the incidence among women in Shijiazhuang is unknown.

methodsAs registered Chinese citizens are entitled to complete public medical insurance coverage, the incidence rate was estimated using reimbursement records of first hospitalization.

resultsBreast cancer is the most common cancer among women in Shijiazhuang. The crude rate and age-standardized incidence rates by China (ASRC) and world (ASRW) standards were 59.6, 48.5 and 45.5/100 000 in 2012. Mean age at diagnosis was 55.1 years. Incidence increased with age, peaking at 165.1 at 70-74. In comparison with urban women in other Chinese cities, incidence in Shijiazhuang was similar to Shanghai (ASRC 46.6) and Suzhou (ASRW 45). When compared with 31 other Chinese cities, Shijiazhuang ranked second highest behind Guangzhou (ASRW 46.6), and the ASRW correlated significantly with gross domestic product per capita among the 32 cities. The breast cancer ASRW in Shijiazhuang was 2.7 times the rate of 41 rural Chinese counties (17). When compared with GLOBOCAN 2012 data according to the Human Development Index, breast cancer incidence in Shijiazhuang matched countries with a high human development index (ASRW 45.2).

conclusionBreast cancer incidence in Shijiazhuang in 2012 was the highest in China, matching the rate in countries with high social economic development. This rate may continue to rise, parallel with urbanization, and may be associated with changing reproductive patterns and Westernization. Prevention methods need to be incorporated.

Indexed as

AdolescentAdultAgedAge DistributionBreast NeoplasmsChinaFemaleHumansIncidenceInsurance Claim ReviewMiddle AgedRisk FactorsRural PopulationUrban PopulationYoung AdultBirth ratefemale breast cancerurbanizationurban Shijiazhuangwesternization

Identifiers

PMID27766774
PMCPMC5130316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.